Pirfenidone, with CAS number 53179-13-8, is a critical pharmaceutical component recognized for its antifibrotic properties, particularly in the treatment of Idiopathic Pulmonary Fibrosis (IPF). NINGBO INNO PHARMCHEM CO., LTD. supplies this high-quality powder, supporting its use in a range of therapeutic and research applications.

The primary function of Pirfenidone is to slow the progression of lung fibrosis by inhibiting key cellular processes that contribute to scarring. Clinical trials have validated its effectiveness in preserving lung function and improving the prognosis for IPF patients. This makes it an indispensable API for pharmaceutical formulations aimed at managing this chronic respiratory condition.

Emerging research is also exploring the potential of Pirfenidone beyond lung health. Its demonstrated antifibrotic and anti-inflammatory effects suggest possible applications in treating cardiac diseases characterized by fibrosis, such as Heart Failure with Preserved Ejection Fraction (HFpEF). Preclinical studies have shown promising results in animal models, indicating a potential expansion of Pirfenidone's therapeutic reach.

NINGBO INNO PHARMCHEM CO., LTD. is dedicated to maintaining the highest standards for its Pirfenidone product. This commitment ensures that the API is of pharmaceutical grade, suitable for demanding applications in both human medicine and advanced research. Companies seeking a reliable and high-quality source for Pirfenidone can confidently turn to NINGBO INNO PHARMCHEM CO., LTD. for their needs.